David I. Brown

Washington, D.C.
  • 555 Eleventh Street, NW
  • Suite 1000
  • Washington, D.C. 20004-1304
  • USA
Profile Experience

David Brown advises private equity firms as well as public and private companies on a range of corporate transactions and related matters. He previously served as Global Co-Chair of the firm’s Private Equity Practice as well as Local Co-Chair of the Corporate Department.

Mr. Brown regularly represents clients in a broad range of industries on complex M&A transactions, including:

  • Leveraged acquisitions
  • Divestitures of divisions and product lines
  • Going-private transactions
  • Other strategic acquisitions, joint ventures, and investments

He advises some of Latham’s largest and most influential private equity clients on a full spectrum of transactions, leveraging more than two decades of experience and a thorough and analytical approach to often complex and cross-border deal-making.

Mr. Brown’s representative work includes advising:

  • Platinum Equity in its US$2.5 billion acquisition, and subsequent sale, of Multi-Color, a provider of label solutions with business interests in the North America, Latin America, Europe, Middle East, Africa, and Asia
  • The Carlyle Group in its acquisition and subsequent sale of Workforce Logiq, a leading global provider of workforce management software and services
  • Platinum Equity in its acquisition of a controlling stake in SVP-Singer Holdings, Inc., the world’s largest consumer sewing machine company
  • Nesco Holdings in its acquisition of Custom Truck One Source, a provider of specialized truck and heavy equipment solutions
  • X-Chem, Inc., the industry-leading provider of DNA-Encoded Library-based discovery services, and its stockholders, The Carlyle Group and Hellman & Friedman, in X-Chem’s sale to GHO Capital
  • Platinum Equity in its joint venture with Ball Corp. and acquisition of Ball Corp.’s tinplate food and aerosol packaging businesses
  • Platinum Equity in its US$3.85 billion acquisition of Husky Injection Molding Systems, a leading supplier of injection molding equipment and services to the global plastics industry
  • Platinum Equity in its public-to-private acquisition of Nasdaq-listed Electro Rent, a provider of new and used electronic test and measurement equipment and personal computer rentals, and the subsequent add-on acquisition of UK-based Microlease
  • The Carlyle Group in its minority investment in Ion Investment Group, an Ireland-domiciled developer of electric flow trading, commodity, treasury, and risk management solutions
  • Pharmaceutical Product Development, a leading global contract research organization, in a number of transactions
  • The Carlyle Group in its US$4.15 billion acquisition from Johnson & Johnson of Ortho-Clinical Diagnostics, a global provider of solutions for screening and confirming diseases
  • The Carlyle Group in its US$350 million preferred stock investment in Genesee & Wyoming, the largest US short-line railroad operator, in connection with G&W’s US$1.4 billion acquisition of rival, RailAmerica
  • Platinum Equity in its acquisition of a recreational and fishing boat business sold by Genmar Holdings in a 363 sale, the subsequent add-on acquisition of Brunswick Corporation’s Triton Boats, and ultimate sale of the recreational boat business to Beneteau Group and the fishing boat business to BassPro
  • Booz Allen Hamilton in the US$2.54 billion sale of its government consulting business to The Carlyle Group, and the spin-off of Booz Allen’s commercial consulting business to its partners
  • Koch Industries in numerous transactions, including its US$4.4 billion acquisition of INVISTA, DuPont’s former Textiles & Interiors division, and the US$300 million sale of its asphalt products division
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.